Glenmark Pharmaceuticals Sees Surge in Trading Volume and Investor Participation

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active equities today, with a total traded volume of 931,465 shares and a total traded value of approximately Rs 202.89 crores. The stock opened at Rs 2,170.1 and reached a day high of Rs 2,191.9, while the day low was recorded at Rs 2,138.5. As of the latest update, the last traded price (LTP) stands at Rs 2,188.8, reflecting a 0.45% increase for the day.
Currently, Glenmark is trading close to its 52-week high, just 4.85% away from Rs 2,284.8. The stock has shown consistent performance, trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant rise in investor participation, with delivery volume on July 11 surging by 714.75% compared to the 5-day average.

In terms of liquidity, Glenmark Pharmaceuticals is deemed liquid enough for a trade size of Rs 19.92 crores, based on 2% of the 5-day average traded value. Overall, Glenmark Pharmaceuticals continues to demonstrate solid performance metrics within the Pharmaceuticals & Biotechnology sector.